Temat: "HIV infections" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Factors associated with vertical transmission of HIV in the Western Cape, South Africa: a retrospective cohort analysis.
Autorzy:: Anderson K; Centre for Infectious Disease Epidemiology and Research, School of Public Health, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
Kalk E; Centre for Infectious Disease Epidemiology and Research, School of Public Health, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
Heekes A; Health Intelligence, Western Cape Department of Health, Cape Town, South Africa.
Phelanyane F; Health Intelligence, Western Cape Department of Health, Cape Town, South Africa.
Jacob N; Division of Public Health Medicine, School of Public Health, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
Boulle A; Centre for Infectious Disease Epidemiology and Research, School of Public Health, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.; Health Intelligence, Western Cape Department of Health, Cape Town, South Africa.; Division of Public Health Medicine, School of Public Health, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
Mehta U; Centre for Infectious Disease Epidemiology and Research, School of Public Health, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
Kassanjee R; Centre for Infectious Disease Epidemiology and Research, School of Public Health, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
Sridhar G; ViiV Healthcare, Durham, North Carolina, USA.
Ragone L; ViiV Healthcare, Durham, North Carolina, USA.
Vannappagari V; ViiV Healthcare, Durham, North Carolina, USA.; Department of Epidemiology, Gilling School of Public Health, University of North Carolina, Chapel Hill, North Carolina, USA.
Davies MA; Centre for Infectious Disease Epidemiology and Research, School of Public Health, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.; Health Intelligence, Western Cape Department of Health, Cape Town, South Africa.; Division of Public Health Medicine, School of Public Health, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.; Pokaż więcej
Źródło:: Journal of the International AIDS Society [J Int AIDS Soc] 2024 Mar; Vol. 27 (3), pp. e26235.
Typ publikacji:: Journal Article
MeSH Terms:: HIV Infections*/diagnosis
HIV Infections*/drug therapy
HIV Infections*/epidemiology
Anti-HIV Agents*/therapeutic use
Pregnancy Complications, Infectious*/epidemiology
Pregnancy Complications, Infectious*/drug therapy
Pregnancy ; Infant ; Infant, Newborn ; Female ; Humans ; Young Adult ; Adult ; Retrospective Studies ; South Africa/epidemiology ; Anti-Retroviral Agents/therapeutic use ; Cohort Studies ; Infectious Disease Transmission, Vertical/prevention & control

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: Facilitators and barriers to community pharmacy PrEP delivery: a scoping review.
Autorzy:: Harrison C; National Institute for Health and Care Research Applied Research Collaboration West (NIHR ARC West), Bristol, UK.; National Institute for Health and Care Research, Health Protection Research Unit (HPRU) in Behavioural Science and Evaluation, Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.; Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
Family H; National Institute for Health and Care Research Applied Research Collaboration West (NIHR ARC West), Bristol, UK.; National Institute for Health and Care Research, Health Protection Research Unit (HPRU) in Behavioural Science and Evaluation, Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.; Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
Kesten J; National Institute for Health and Care Research Applied Research Collaboration West (NIHR ARC West), Bristol, UK.; National Institute for Health and Care Research, Health Protection Research Unit (HPRU) in Behavioural Science and Evaluation, Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.; Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
Denford S; National Institute for Health and Care Research, Health Protection Research Unit (HPRU) in Behavioural Science and Evaluation, Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.; Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
Scott A; National Institute for Health and Care Research Applied Research Collaboration West (NIHR ARC West), Bristol, UK.; Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
Dawson S; Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
Scott J; Centre for Academic Primary Care (CAPC), Bristol Medical School, University of Bristol, Bristol, UK.
Sabin C; Institute for Global Health, UCL, Royal Free Campus, London, UK.; NIHR HPRU in Blood-Borne and Sexually Transmitted Infections at UCL, London, UK.
Copping J; Communities and Public Health, Bristol City Council, College Green Bristol, Bristol, UK.
Harryman L; Unity Sexual Health, University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, UK.
Cochrane S; The Riverside Clinic, Royal United Hospitals Bath NHS Foundation Trust, Bristol, UK.
Horwood J; National Institute for Health and Care Research Applied Research Collaboration West (NIHR ARC West), Bristol, UK.; National Institute for Health and Care Research, Health Protection Research Unit (HPRU) in Behavioural Science and Evaluation, Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.; Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.; Centre for Academic Primary Care (CAPC), Bristol Medical School, University of Bristol, Bristol, UK.; Pokaż więcej
Źródło:: Journal of the International AIDS Society [J Int AIDS Soc] 2024 Mar; Vol. 27 (3), pp. e26232.
Typ publikacji:: Journal Article; Review
MeSH Terms:: Pharmacies*
HIV Infections*/prevention & control
HIV Infections*/drug therapy
Anti-HIV Agents*/therapeutic use
Humans ; United States ; Motivation ; Income

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: A conjoint experiment of three placebo rectal products used with receptive anal sex: results from MTN-035.
Autorzy:: Bauermeister J; University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Lin W; University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Tingler R; University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Liu A; Bridge HIV at the San Francisco Department of Public Health, San Francisco, California, USA.
Chariyalertsak S; Research Institute for Health Sciences, Chiang Mai University, Chiang Mai, Thailand.
Hoesley C; University of Alabama at Birmingham, Birmingham, Alabama, USA.
Gonzales P; IMPACTA, Asociación Civil Impacta Salud y Educación, San Miguel CRS, Lima, Perú.
Ho K; University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Kayange N; Blantyre CRS, Johns Hopkins University Research Project, Blantyre, Malawi.
Phillips TP; Wits Reproductive Health and HIV Institute, Johannesburg, South Africa.
Johnson S; FHI 360, Durham, North Carolina, USA.
Brown E; Statistical Center for HIV/AIDS Research & Prevention, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
Zemanek J; Statistical Center for HIV/AIDS Research & Prevention, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
Jacobson CE; FHI 360, Durham, North Carolina, USA.
Doncel GF; CONRAD, Eastern Virginia Medical School, Norfolk, Virginia, USA.
Piper J; Division of AIDS, United States National Institute of Health, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, USA.; Pokaż więcej
Corporate Authors:: MTN-035 Protocol Team for the Microbicide Trials Network
Źródło:: Journal of the International AIDS Society [J Int AIDS Soc] 2024 Mar; Vol. 27 (3), pp. e26219.
Typ publikacji:: Randomized Controlled Trial; Journal Article
MeSH Terms:: Anti-Infective Agents*/therapeutic use
HIV Infections*/drug therapy
HIV Infections*/prevention & control
Sexual and Gender Minorities*
Humans ; Male ; Homosexuality, Male ; Sexual Behavior ; United States ; Female ; Adolescent ; Young Adult ; Adult

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: Sexual behaviour and STIs among MSM living with HIV in the PrEP era: the French ANRS PRIMO cohort study.
Autorzy:: Baltes V; Inserm, CESP U1018, Le Kremlin-Bicêtre, France.; Université Paris Saclay, Faculté de médecine, Le Kremlin-Bicêtre, France.
de Boissieu P; Inserm, CESP U1018, Le Kremlin-Bicêtre, France.; AP-HP Epidémiologie et Santé publique, Hôpital Bicêtre, Le Kremlin-Bicêtre, France.
Champenois K; Université de Paris Cité et Université Sorbonne Paris Nord, Inserm, IAME, Paris, France.
Luan L; Inserm, CESP U1018, Le Kremlin-Bicêtre, France.; AP-HP Epidémiologie et Santé publique, Hôpital Bicêtre, Le Kremlin-Bicêtre, France.
Seng R; Inserm, CESP U1018, Le Kremlin-Bicêtre, France.; Université Paris Saclay, Faculté de médecine, Le Kremlin-Bicêtre, France.; AP-HP Epidémiologie et Santé publique, Hôpital Bicêtre, Le Kremlin-Bicêtre, France.
Essat A; Inserm, CESP U1018, Le Kremlin-Bicêtre, France.; Université Paris Saclay, Faculté de médecine, Le Kremlin-Bicêtre, France.; AP-HP Epidémiologie et Santé publique, Hôpital Bicêtre, Le Kremlin-Bicêtre, France.
Novelli S; Inserm, CESP U1018, Le Kremlin-Bicêtre, France.; Université Paris Saclay, Faculté de médecine, Le Kremlin-Bicêtre, France.
Spire B; Aix Marseille Univ, Inserm, IRD, SESSTIM, ISSPAM, Marseille, France.
Molina JM; AP-HP Service de maladies infectieuses, Hôpital Saint-Louis, Paris, France.; Université Paris Cité, Paris, France.
Goujard C; Inserm, CESP U1018, Le Kremlin-Bicêtre, France.; Université Paris Saclay, Faculté de médecine, Le Kremlin-Bicêtre, France.; AP-HP Service de médecine interne, Hôpital Bicêtre, Le Kremlin Bicêtre, France.
Meyer L; Inserm, CESP U1018, Le Kremlin-Bicêtre, France.; Université Paris Saclay, Faculté de médecine, Le Kremlin-Bicêtre, France.; AP-HP Epidémiologie et Santé publique, Hôpital Bicêtre, Le Kremlin-Bicêtre, France.; Pokaż więcej
Corporate Authors:: ANRS PRIMO cohort study group; Inserm, CESP U1018, Le Kremlin-Bicêtre, France.
Źródło:: Journal of the International AIDS Society [J Int AIDS Soc] 2024 Mar; Vol. 27 (3), pp. e26226.
Typ publikacji:: Clinical Study; Journal Article
MeSH Terms:: HIV Infections*/drug therapy
HIV Infections*/epidemiology
HIV Infections*/prevention & control
Pre-Exposure Prophylaxis*
Sexual and Gender Minorities*
Sexually Transmitted Diseases*/epidemiology
Adult ; Humans ; Male ; Cohort Studies ; Homosexuality, Male ; Sexual Behavior

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: "Emotional stress is more detrimental than the virus itself": A qualitative study to understand HIV testing and pre-exposure prophylaxis (PrEP) use among internal migrant men in South Africa.
Autorzy:: Nardell MF; Division of Global Health Equity, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA.
Govathson-Mandimika C; Health Economics and Epidemiology Research Office (HE2RO), Johannesburg, South Africa.; Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Garnier S; EHESP French School of Public Health, Paris, France.
Watts A; Harvard University, Boston, Massachusetts, USA.
Babalola D; College of Medicine, University of Ibadan, Ibadan, Nigeria.
Ngcobo N; Health Economics and Epidemiology Research Office (HE2RO), Johannesburg, South Africa.; Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Long L; Health Economics and Epidemiology Research Office (HE2RO), Johannesburg, South Africa.; Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.; Department of Global Health, Boston University School of Public Health, Boston, Massachusetts, USA.
Lurie MN; Brown University School of Public Health, Brown University, Providence, Rhode Island, USA.
Miot J; Health Economics and Epidemiology Research Office (HE2RO), Johannesburg, South Africa.; Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Pascoe S; Health Economics and Epidemiology Research Office (HE2RO), Johannesburg, South Africa.; Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Katz IT; Harvard Medical School, Boston, Massachusetts, USA.; Division of Women's Health, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Pokaż więcej
Źródło:: Journal of the International AIDS Society [J Int AIDS Soc] 2024 Mar; Vol. 27 (3), pp. e26225.
Typ publikacji:: Journal Article
MeSH Terms:: HIV Infections*/diagnosis
HIV Infections*/drug therapy
HIV Infections*/prevention & control
Pre-Exposure Prophylaxis*
Transients and Migrants*
Anti-HIV Agents*/therapeutic use
Male ; Humans ; South Africa ; Stress, Psychological ; HIV Testing

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 6.

Tytuł:: Effect of differentiated direct-to-pharmacy PrEP refill visits supported with client HIV self-testing on clinic visit time and early PrEP continuation.
Autorzy:: Zewdie KB; Department of Epidemiology, University of Washington, Seattle, Washington, USA.; Department of Global Health, University of Washington, Seattle, Washington, USA.
Ngure K; Department of Global Health, University of Washington, Seattle, Washington, USA.; Department of Community Health, Jomo Kenyatta University of Agriculture and Technology, Nairobi, Kenya.
Mwangi M; Partners in Health Research and Development, Center for Clinical Research, Kenya Medical Research Institute, Nairobi, Kenya.
Mwangi D; Partners in Health Research and Development, Center for Clinical Research, Kenya Medical Research Institute, Nairobi, Kenya.
Maina S; Partners in Health Research and Development, Center for Clinical Research, Kenya Medical Research Institute, Nairobi, Kenya.
Etyang L; Partners in Health Research and Development, Center for Clinical Research, Kenya Medical Research Institute, Nairobi, Kenya.
Maina G; Partners in Health Research and Development, Center for Clinical Research, Kenya Medical Research Institute, Nairobi, Kenya.
Ogello V; Partners in Health Research and Development, Center for Clinical Research, Kenya Medical Research Institute, Nairobi, Kenya.
Owidi E; Partners in Health Research and Development, Center for Clinical Research, Kenya Medical Research Institute, Nairobi, Kenya.
Mugo NR; Department of Global Health, University of Washington, Seattle, Washington, USA.; Partners in Health Research and Development, Center for Clinical Research, Kenya Medical Research Institute, Nairobi, Kenya.
Baeten JM; Department of Global Health, University of Washington, Seattle, Washington, USA.; Department of Medicine, University of Washington, Seattle, Washington, USA.
Mugwanya KK; Department of Epidemiology, University of Washington, Seattle, Washington, USA.; Department of Global Health, University of Washington, Seattle, Washington, USA.; Pokaż więcej
Źródło:: Journal of the International AIDS Society [J Int AIDS Soc] 2024 Mar; Vol. 27 (3), pp. e26222.
Typ publikacji:: Journal Article
MeSH Terms:: Adenine*/analogs & derivatives
HIV Infections*/diagnosis
HIV Infections*/drug therapy
HIV Infections*/prevention & control
Organophosphates*
Pharmacy*
Adult ; Female ; Humans ; Ambulatory Care ; HIV ; HIV Testing ; Kenya ; Self-Testing ; Male

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 7.

Tytuł:: Optimizing health resource allocation for improving timely HIV diagnosis in China.
Autorzy:: He S; China-Australia Joint Research Center for Infectious Diseases, School of Public Health, Xi'an Jiaotong University Health Science Center, Xi'an, China.
Dong W; National Center for AIDS/STD Control and Prevention (NCAIDS), Chinese Center for Disease Control and Prevention (China CDC), Beijing, China.
Fairley CK; Melbourne Sexual Health Centre, Alfred Health, Melbourne, Victoria, Australia.; Central Clinical School, Faculty of Medicine, Monash University, Melbourne, Victoria, Australia.
Li Z; China-Australia Joint Research Center for Infectious Diseases, School of Public Health, Xi'an Jiaotong University Health Science Center, Xi'an, China.
Wei Y; China-Australia Joint Research Center for Infectious Diseases, School of Public Health, Xi'an Jiaotong University Health Science Center, Xi'an, China.
Lai H; China-Australia Joint Research Center for Infectious Diseases, School of Public Health, Xi'an Jiaotong University Health Science Center, Xi'an, China.
Li R; China-Australia Joint Research Center for Infectious Diseases, School of Public Health, Xi'an Jiaotong University Health Science Center, Xi'an, China.
Lu P; China-Australia Joint Research Center for Infectious Diseases, School of Public Health, Xi'an Jiaotong University Health Science Center, Xi'an, China.
Shen M; China-Australia Joint Research Center for Infectious Diseases, School of Public Health, Xi'an Jiaotong University Health Science Center, Xi'an, China.; Key Laboratory for Disease Prevention and Control and Health Promotion of Shaanxi Province, Xi'an, China.; The Interdisciplinary Center for Mathematics and Life Sciences, School of Mathematics and Statistics, Xi'an Jiaotong University, Xi'an, China.; Key Laboratory of Environment and Genes Related to Diseases (Xi'an Jiaotong University), Ministry of Education, Xi'an, China.
Wu Z; National Center for AIDS/STD Control and Prevention (NCAIDS), Chinese Center for Disease Control and Prevention (China CDC), Beijing, China.
Zhang L; China-Australia Joint Research Center for Infectious Diseases, School of Public Health, Xi'an Jiaotong University Health Science Center, Xi'an, China.; Melbourne Sexual Health Centre, Alfred Health, Melbourne, Victoria, Australia.; Central Clinical School, Faculty of Medicine, Monash University, Melbourne, Victoria, Australia.; Pokaż więcej
Źródło:: Journal of the International AIDS Society [J Int AIDS Soc] 2024 Mar; Vol. 27 (3), pp. e26221.
Typ publikacji:: Journal Article
MeSH Terms:: Sexual and Gender Minorities*
HIV Infections*/diagnosis
HIV Infections*/epidemiology
Pregnancy ; Male ; Humans ; Female ; Homosexuality, Male ; China/epidemiology ; Resource Allocation

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 8.

Tytuł:: Phase 1 randomized pharmacokinetic and safety study of a 90-day tenofovir vaginal ring in the United States.
Autorzy:: Liu AY; Bridge HIV, San Francisco Department of Public Health, San Francisco, California, USA.; Department of Medicine, University of California, San Francisco, San Francisco, California, USA.
Gundacker H; Statistical Center for HIV/AIDS Research & Prevention, Fred Hutchinson Cancer Center, Seattle, Washington, USA.
Richardson B; Departments of Biostatistics and Global Health, University of Washington, Seattle, Washington, USA.; Vaccine and Infectious Disease and Public Health Sciences Divisions, Fred Hutchinson Cancer Center, Seattle, Washington, USA.
Chen BA; Department of Obstetrics, Gynecology, and Reproductive Sciences, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.; Magee-Womens Research Institute, Pittsburgh, Pennsylvania, USA.
Hoesley C; University of Alabama at Birmingham, Birmingham, Alabama, USA.
van der Straten A; Department of Medicine, University of California, San Francisco, San Francisco, California, USA.; ASTRA Consulting, Kensington, California, USA.
Brown A; Statistical Center for HIV/AIDS Research & Prevention, Fred Hutchinson Cancer Center, Seattle, Washington, USA.
Beamer M; Magee-Womens Research Institute, Pittsburgh, Pennsylvania, USA.
Robinson J; Division of Gynecology and Obstetrics, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Jacobson CE; Magee-Womens Research Institute, Pittsburgh, Pennsylvania, USA.
Scheckter R; FHI 360, Durham, North Carolina, USA.
Bunge K; Department of Obstetrics, Gynecology, and Reproductive Sciences, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Schwartz J; CONRAD, Eastern Virginia Medical School, Norfolk, Virginia, USA.
Thurman A; CONRAD, Eastern Virginia Medical School, Norfolk, Virginia, USA.
Piper JM; Division of AIDS, National Institutes of Health, Bethesda, Maryland, USA.
Marzinke MA; Division of Clinical Pharmacology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.; Pokaż więcej
Corporate Authors:: MTN-038 Protocol Team for the Microbicide Trials Network
Źródło:: Journal of the International AIDS Society [J Int AIDS Soc] 2024 Mar; Vol. 27 (3), pp. e26223.
Typ publikacji:: Randomized Controlled Trial; Clinical Trial, Phase I; Journal Article
MeSH Terms:: HIV Infections*/drug therapy
HIV Infections*/prevention & control
Tenofovir*/adverse effects
Tenofovir*/pharmacokinetics
Adult ; Female ; Humans ; Adenine ; Herpesvirus 2, Human ; Microbiota ; United States

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 9.

Tytuł:: What does the scale-up of long-acting HIV pre-exposure prophylaxis mean for the global hepatitis B epidemic?
Autorzy:: Mohareb AM; Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, Massachusetts, USA.; Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, USA.; Harvard University Center for AIDS Research, Boston, Massachusetts, USA.
Kouamé MG; Département de Santé Publique, UFR d'Odonto-stomatologie, Université Félix Houphouët Boigny, Abidjan, Côte d'Ivoire.
Nouaman M; Département de Santé Publique, UFR d'Odonto-stomatologie, Université Félix Houphouët Boigny, Abidjan, Côte d'Ivoire.
Kim AY; Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, USA.; Harvard University Center for AIDS Research, Boston, Massachusetts, USA.
Larmarange J; Centre Population et Développement, Université Paris Cité, IRD, Inserm, Paris, France.
Neilan AM; Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, Massachusetts, USA.; Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, USA.; Harvard University Center for AIDS Research, Boston, Massachusetts, USA.; Division of General Academic Pediatrics, Department of Pediatrics, Massachusetts General Hospital, Boston, Massachusetts, USA.
Lacombe K; Sorbonne Université, IPLESP, Paris, France.; Department of Infectious Diseases, St. Antoine Hospital, AP-HP, Paris, France.
Freedberg KA; Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, Massachusetts, USA.; Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, USA.; Harvard University Center for AIDS Research, Boston, Massachusetts, USA.; Department of General Internal Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.
Boyd A; Stichting HIV Monitoring, Amsterdam, the Netherlands.; Department of Infectious Diseases, Public Health Service of Amsterdam, Amsterdam, the Netherlands.; Amsterdam UMC, Infectious Diseases, Amsterdam, the Netherlands.; Amsterdam Institute for Infection and Immunity, Infectious Diseases, Amsterdam, the Netherlands.
Coffie P; Département de Santé Publique, UFR d'Odonto-stomatologie, Université Félix Houphouët Boigny, Abidjan, Côte d'Ivoire.; Département de Dermatologie et Infectiologie, Université Félix Houphouët-Boigny, Abidjan, Côte d'Ivoire.
Hyle EP; Medical Practice Evaluation Center, Massachusetts General Hospital, Boston, Massachusetts, USA.; Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, USA.; Harvard University Center for AIDS Research, Boston, Massachusetts, USA.; Pokaż więcej
Źródło:: Journal of the International AIDS Society [J Int AIDS Soc] 2024 Mar; Vol. 27 (3), pp. e26218.
Typ publikacji:: Journal Article
MeSH Terms:: Pre-Exposure Prophylaxis*
HIV Infections*/drug therapy
HIV Infections*/epidemiology
HIV Infections*/prevention & control
Hepatitis B*/drug therapy
Hepatitis B*/epidemiology
Hepatitis B*/prevention & control
Humans ; Tenofovir/therapeutic use ; Antiviral Agents/therapeutic use

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 10.

Tytuł:: The development of a conceptual framework on PrEP stigma among adolescent girls and young women in sub-Saharan Africa.
Autorzy:: Hartmann M; Women's Global Health Imperative, RTI International, Berkeley, California, USA.; Department of Global Public Health, Karolinska Institutet, Stockholm, Sweden.
Nyblade L; Women's Global Health Imperative, RTI International, Berkeley, California, USA.
Otticha S; Impact Research Development Organization, Kisumu, Kenya.
Marton T; Women's Global Health Imperative, RTI International, Berkeley, California, USA.
Agot K; Impact Research Development Organization, Kisumu, Kenya.
Roberts ST; Women's Global Health Imperative, RTI International, Berkeley, California, USA.; Pokaż więcej
Źródło:: Journal of the International AIDS Society [J Int AIDS Soc] 2024 Feb; Vol. 27 (2), pp. e26213.
Typ publikacji:: Review; Journal Article
MeSH Terms:: HIV Infections*/prevention & control
HIV Infections*/drug therapy
Anti-HIV Agents*/therapeutic use
Pre-Exposure Prophylaxis*/methods
Humans ; Adolescent ; Female ; Kenya ; Sexual Behavior

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 11.

Tytuł:: My Way: development and preliminary evaluation of a novel delivery system for PrEP and other sexual health needs of young women in Western Kenya.
Autorzy:: Haberer JE; Massachusetts General Hospital, Boston, Massachusetts, USA.; Harvard Medical School, Boston, Massachusetts, USA.
Oware K; Kenya Medical Research Institute, Kisumu, Kenya.
Juma L; Kenya Medical Research Institute, Kisumu, Kenya.
Nyerere B; Kenya Medical Research Institute, Kisumu, Kenya.
Momanyi V; Kenya Medical Research Institute, Kisumu, Kenya.
Odoyo J; Kenya Medical Research Institute, Kisumu, Kenya.
Garrison L; Massachusetts General Hospital, Boston, Massachusetts, USA.
Bhagat J; Ark Africa, Nairobi, Kenya.
Musinguzi N; Global Health Collaborative, Mbarara, Uganda.
Baeten JM; University of Washington, Seattle, Washington, USA.
Siegler A; Emory University, Atlanta, Georgia, USA.
Bukusi EA; Kenya Medical Research Institute, Kisumu, Kenya.; University of Washington, Seattle, Washington, USA.; Pokaż więcej
Źródło:: Journal of the International AIDS Society [J Int AIDS Soc] 2024 Feb; Vol. 27 (2), pp. e26217.
Typ publikacji:: Randomized Controlled Trial; Journal Article
MeSH Terms:: HIV Infections*/diagnosis
HIV Infections*/prevention & control
HIV Infections*/drug therapy
Anti-HIV Agents*/therapeutic use
Sexual Health*
Sexually Transmitted Diseases*/diagnosis
Sexually Transmitted Diseases*/prevention & control
Pre-Exposure Prophylaxis*
Organophosphates*
Adenine/*analogs & derivatives
Humans ; Female ; Young Adult ; Adult ; Adolescent ; Kenya/epidemiology

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 12.

Tytuł:: Integrating methadone into primary care settings in Ukraine: effects on provider stigma and knowledge.
Autorzy:: Bromberg DJ; Yale School of Public Health, Yale University, New Haven, Connecticut, USA.; Center for Interdisciplinary Research on AIDS, Yale University, New Haven, Connecticut, USA.; Yale School of Medicine, Yale University, New Haven, Connecticut, USA.
Machavariani E; Yale School of Medicine, Yale University, New Haven, Connecticut, USA.
Madden LM; Yale School of Medicine, Yale University, New Haven, Connecticut, USA.; APT Foundation, New Haven, Connecticut, USA.
Dumchev K; Ukrainian Institute on Public Health Policy, Kyiv, Ukraine.
LaMonaca K; Yale School of Medicine, Yale University, New Haven, Connecticut, USA.
Earnshaw VA; University of Delaware, Newark, Delaware, USA.
Pykalo I; Ukrainian Institute on Public Health Policy, Kyiv, Ukraine.
Filippovych M; Ukrainian Institute on Public Health Policy, Kyiv, Ukraine.
Haddad MS; Center for Key Populations, Community Health Center, Inc., Middletown, Connecticut, USA.
Dvoriak S; Ukrainian Institute on Public Health Policy, Kyiv, Ukraine.
Altice FL; Yale School of Public Health, Yale University, New Haven, Connecticut, USA.; Center for Interdisciplinary Research on AIDS, Yale University, New Haven, Connecticut, USA.; Yale School of Medicine, Yale University, New Haven, Connecticut, USA.; University of Delaware, Newark, Delaware, USA.; Pokaż więcej
Źródło:: Journal of the International AIDS Society [J Int AIDS Soc] 2024 Feb; Vol. 27 (2), pp. e26202.
Typ publikacji:: Randomized Controlled Trial; Journal Article
MeSH Terms:: Substance Abuse, Intravenous*/complications
HIV Infections*/drug therapy
HIV Infections*/prevention & control
HIV Infections*/complications
Humans ; Methadone/therapeutic use ; Analgesics, Opioid/therapeutic use ; Ukraine ; Primary Health Care

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 13.

Tytuł:: Long-term retention on antiretroviral treatment after enrolment in prevention of vertical HIV transmission services: a prospective cohort study in Dar es Salaam, Tanzania.
Autorzy:: Urrio RF; Management and Development for Health, Dar es Salaam, Tanzania.; Department of Obstetrics and Gynacology, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania.
Lyatuu GW; Management and Development for Health, Dar es Salaam, Tanzania.; Department of Global Public Health, Karolinska Institutet, Stockholm, Sweden.
Sando D; Management and Development for Health, Dar es Salaam, Tanzania.
Mahande MJ; Management and Development for Health, Dar es Salaam, Tanzania.
Philipo E; Management and Development for Health, Dar es Salaam, Tanzania.
Naburi H; Department of Pediatric and Child Health, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania.
Lyaruu P; Management and Development for Health, Dar es Salaam, Tanzania.
Kimonge A; Management and Development for Health, Dar es Salaam, Tanzania.
Mayogu K; Management and Development for Health, Dar es Salaam, Tanzania.
Simba B; Management and Development for Health, Dar es Salaam, Tanzania.
Kibao AM; Office of the Regional Administrative Secretary, Dar es Salaam, Tanzania.
Msangi M; Ministry of Health, Dodoma, Tanzania.
Zeebari Z; Department of Global Public Health, Karolinska Institutet, Stockholm, Sweden.
Biberfeld G; Department of Global Public Health, Karolinska Institutet, Stockholm, Sweden.
Ekström AM; Department of Global Public Health, Karolinska Institutet, Stockholm, Sweden.; Department of Infectious Disease/Venhälsan, South General Hospital, Stockholm, Sweden.
Kilewo C; Department of Obstetrics and Gynacology, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania.
Kågesten AE; Department of Global Public Health, Karolinska Institutet, Stockholm, Sweden.; Pokaż więcej
Źródło:: Journal of the International AIDS Society [J Int AIDS Soc] 2024 Feb; Vol. 27 (2), pp. e26186.
Typ publikacji:: Journal Article
MeSH Terms:: HIV Infections*/drug therapy
HIV Infections*/prevention & control
Anti-HIV Agents*/therapeutic use
Humans ; Female ; Pregnancy ; Child ; Aged ; Prospective Studies ; Tanzania/epidemiology ; Anti-Retroviral Agents/therapeutic use ; Breast Feeding

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 14.

Tytuł:: Healthcare provisions associated with multiple HIV-related outcomes among adolescent girls and young women living with HIV in South Africa: a cross-sectional study.
Autorzy:: Toska E; Centre for Social Science Research, University of Cape Town, Cape Town, South Africa.; Department of Social Policy and Intervention, University of Oxford, Oxford, UK.
Zhou S; Centre for Social Science Research, University of Cape Town, Cape Town, South Africa.; Division of Social and Behavioural Sciences, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
Laurenzi CA; Institute for Life Course Health Research, Department of Global Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
Saal W; Centre for Social Science Research, University of Cape Town, Cape Town, South Africa.
Rudgard W; Department of Social Policy and Intervention, University of Oxford, Oxford, UK.
Wittesaele C; Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK.
Langwenya N; Department of Social Policy and Intervention, University of Oxford, Oxford, UK.
Jochim J; Department of Social Policy and Intervention, University of Oxford, Oxford, UK.
Banougnin BH; Centre for Social Science Research, University of Cape Town, Cape Town, South Africa.
Gulaid L; UNICEF Eastern and Southern Africa Office (UNICEF-ESARO), Nairobi, Kenya.
Armstrong A; UNICEF Eastern and Southern Africa Office (UNICEF-ESARO), Nairobi, Kenya.
Sherman G; National Institute for Communicable Diseases, Johannesburg, South Africa.; Department of Paediatrics and Child Health, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Edun O; MRC Centre for Global Infectious Disease Analysis, School of Public Health, Imperial College London, London, UK.
Sherr L; Institute for Global Health, University College London, London, UK.
Cluver L; Division of Social and Behavioural Sciences, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.; Department of Psychiatry and Mental Health, University of Cape Town, Cape Town, South Africa.; Pokaż więcej
Źródło:: Journal of the International AIDS Society [J Int AIDS Soc] 2024 Feb; Vol. 27 (2), pp. e26212.
Typ publikacji:: Journal Article
MeSH Terms:: HIV Infections*/drug therapy
HIV Infections*/epidemiology
Pregnancy ; Humans ; Female ; Adolescent ; Child ; Young Adult ; Adult ; South Africa/epidemiology ; Cross-Sectional Studies ; Ambulatory Care Facilities ; Delivery of Health Care

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 15.

Tytuł:: Body weight and blood pressure changes on dolutegravir-, efavirenz- or atazanavir-based antiretroviral therapy in Zimbabwe: a longitudinal study.
Autorzy:: Shamu T; Newlands Clinic, Harare, Zimbabwe.; Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.; Graduate School of Health Sciences, University of Bern, Bern, Switzerland.
Egger M; Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.; Centre for Infectious Disease Epidemiology and Research, School of Public Health, University of Cape Town, Cape Town, South Africa.; Population Health Sciences, Bristol Medical School, University of Bristol, Bristol, UK.
Mudzviti T; Newlands Clinic, Harare, Zimbabwe.; Department of Pharmacy and Pharmaceutical Sciences, University of Zimbabwe, Harare, Zimbabwe.
Chimbetete C; Newlands Clinic, Harare, Zimbabwe.
Manasa J; Innovation Hub, University of Zimbabwe, Harare, Zimbabwe.
Anderegg N; Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.; Centre for Infectious Disease Epidemiology and Research, School of Public Health, University of Cape Town, Cape Town, South Africa.; Pokaż więcej
Źródło:: Journal of the International AIDS Society [J Int AIDS Soc] 2024 Feb; Vol. 27 (2), pp. e26216.
Typ publikacji:: Journal Article
MeSH Terms:: HIV Infections*/drug therapy
HIV Infections*/epidemiology
Hypertension*
Anti-HIV Agents*/adverse effects
Piperazines*
Pyridones*
Alkynes*
Oxazines*
Cyclopropanes*
Adult ; Male ; Humans ; Female ; Longitudinal Studies ; Atazanavir Sulfate/adverse effects ; Blood Pressure ; Zimbabwe/epidemiology ; Bayes Theorem ; Benzoxazines/adverse effects ; Heterocyclic Compounds, 3-Ring/adverse effects ; Weight Gain ; Body Weight

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 16.

Tytuł:: Temporal dynamics and drivers of durable HIV viral load suppression and persistent high- and low-level viraemia during Universal Test and Treat scale-up in Uganda: a population-based study.
Autorzy:: Rosen JG; Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Ssekubugu R; Rakai Health Sciences Program, Entebbe, Uganda.
Chang LW; Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.; Rakai Health Sciences Program, Entebbe, Uganda.; Division of Infectious Diseases, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Ssempijja V; Rakai Health Sciences Program, Entebbe, Uganda.; Clinical Monitoring Research Program Directorate, Frederick National Laboratory for Cancer Research, Frederick, Maryland, USA.
Galiwango RM; Rakai Health Sciences Program, Entebbe, Uganda.
Ssekasanvu J; Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.; Rakai Health Sciences Program, Entebbe, Uganda.
Ndyanabo A; Rakai Health Sciences Program, Entebbe, Uganda.
Kisakye A; Rakai Health Sciences Program, Entebbe, Uganda.
Nakigozi G; Rakai Health Sciences Program, Entebbe, Uganda.
Rucinski KB; Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Patel EU; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
Kennedy CE; Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.; Rakai Health Sciences Program, Entebbe, Uganda.
Nalugoda F; Rakai Health Sciences Program, Entebbe, Uganda.
Kigozi G; Rakai Health Sciences Program, Entebbe, Uganda.
Ratmann O; Department of Mathematics, Imperial College, London, UK.
Nelson LJ; Division of Global HIV and TB, Centers for Disease Control and Prevention, Kampala, Uganda.
Mills LA; Division of Global HIV and TB, Centers for Disease Control and Prevention, Kampala, Uganda.
Kabatesi D; Division of Global HIV and TB, Centers for Disease Control and Prevention, Kampala, Uganda.
Tobian AAR; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.; Department of Pathology, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.
Quinn TC; Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.; Rakai Health Sciences Program, Entebbe, Uganda.; Division of Infectious Diseases, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.; Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Kagaayi J; Rakai Health Sciences Program, Entebbe, Uganda.
Reynolds SJ; Rakai Health Sciences Program, Entebbe, Uganda.; Division of Infectious Diseases, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.; Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
Grabowski MK; Rakai Health Sciences Program, Entebbe, Uganda.; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.; Department of Pathology, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.; Pokaż więcej
Źródło:: Journal of the International AIDS Society [J Int AIDS Soc] 2024 Feb; Vol. 27 (2), pp. e26200.
Typ publikacji:: Journal Article
MeSH Terms:: HIV Infections*/diagnosis
HIV Infections*/drug therapy
HIV Infections*/epidemiology
HIV-1*/genetics
Anti-HIV Agents*/therapeutic use
Male ; Female ; Humans ; Cohort Studies ; Uganda/epidemiology ; Viral Load ; Viremia/diagnosis ; Viremia/drug therapy ; Viremia/epidemiology

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 17.

Tytuł:: HIV pre-exposure prophylaxis programme preferences among sexually active HIV-negative transgender and gender diverse adults in the United States: a conjoint analysis.
Autorzy:: Watson DL; Department of Medicine (Infectious Diseases), University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
Listerud L; Department of Family and Community Health, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Drab RA; Department of Family and Community Health, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Lin WY; Department of Family and Community Health, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
Momplaisir FM; Department of Medicine (Infectious Diseases), University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.
Bauermeister JA; Department of Family and Community Health, University of Pennsylvania, Philadelphia, Pennsylvania, USA.; Pokaż więcej
Źródło:: Journal of the International AIDS Society [J Int AIDS Soc] 2024 Feb; Vol. 27 (2), pp. e26211.
Typ publikacji:: Journal Article
MeSH Terms:: Transgender Persons*
Pre-Exposure Prophylaxis*
HIV Infections*/drug therapy
HIV Infections*/prevention & control
Sexual and Gender Minorities*
Anti-HIV Agents*/therapeutic use
Male ; Adult ; Infant, Newborn ; Humans ; Female ; United States ; Adolescent ; Young Adult ; Middle Aged ; Homosexuality, Male ; Bayes Theorem ; Hormones/therapeutic use

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 18.

Tytuł:: Satisfaction with service delivery among HIV treatment clients enrolled in differentiated and conventional models of care in South Africa: a baseline survey.
Autorzy:: Mokhele I; Health Economics and Epidemiology Research Office, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Huber A; Health Economics and Epidemiology Research Office, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Rosen S; Health Economics and Epidemiology Research Office, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.; Department of Global Health, Boston University School of Public Health, Boston, Massachusetts, USA.
Kaiser JL; Department of Global Health, Boston University School of Public Health, Boston, Massachusetts, USA.
Lekodeba N; Health Economics and Epidemiology Research Office, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Ntjikelane V; Health Economics and Epidemiology Research Office, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Hendrickson C; Health Economics and Epidemiology Research Office, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.; Department of Global Health, Amsterdam Institute for Global Health and Development, Amsterdam University Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
Scott N; Department of Global Health, Boston University School of Public Health, Boston, Massachusetts, USA.
Pascoe S; Health Economics and Epidemiology Research Office, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.; Pokaż więcej
Źródło:: Journal of the International AIDS Society [J Int AIDS Soc] 2024 Mar; Vol. 27 (3), pp. e26233.
Typ publikacji:: Journal Article
MeSH Terms:: HIV Infections*/drug therapy
Anti-HIV Agents*/therapeutic use
Adult ; Humans ; Female ; Male ; South Africa ; Quality of Life ; Delivery of Health Care ; Surveys and Questionnaires

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 19.

Tytuł:: Clinical outcomes and risk factors for immune recovery and all-cause mortality in Latin Americans living with HIV with virological success: a retrospective cohort study.
Autorzy:: Castillo-Rozas G; Laboratory of Molecular and Cellular Virology, Institute of Biomedical Sciences, Faculty of Medicine, University of Chile, Santiago, Chile.; HIV/AIDS Workgroup, Faculty of Medicine, University of Chile, Santiago, Chile.
Tu S; Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Luz PM; Evandro Chagas National Institute of Infectious Diseases, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.
Mejia F; Instituto de Medicina Tropical Alexander von Humboldt, Universidad Peruana Cayetano Heredia, Lima, Perú.
Sierra-Madero J; Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Ciudad de México, México.
Rouzier V; Groupe Haitien d'Etudes du Sarcome de Kaposi et des Infections Opportunistes, Port-au-Prince, Haiti.
Shepherd BE; Department of Biostatistics, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
Cortes CP; HIV/AIDS Workgroup, Faculty of Medicine, University of Chile, Santiago, Chile.; Department of Internal Medicine, Faculty of Medicine, University of Chile, Santiago, Chile.; Hospital Clínico San Borja Arriarán & Fundación Arriarán, Santiago, Chile.; Millenium Institute on Immunology and Immunotherapy, Santiago, Chile.; Pokaż więcej
Źródło:: Journal of the International AIDS Society [J Int AIDS Soc] 2024 Mar; Vol. 27 (3), pp. e26214.
Typ publikacji:: Journal Article
MeSH Terms:: HIV Infections*
Acquired Immunodeficiency Syndrome*/drug therapy
Anti-HIV Agents*/therapeutic use
Humans ; Male ; Retrospective Studies ; Risk Factors ; Drug Therapy, Combination ; CD4 Lymphocyte Count ; Viral Load ; Antiretroviral Therapy, Highly Active

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 20.

Tytuł:: Reasons for disengagement from antiretroviral care in the era of "Treat All" in low- or middle-income countries: a systematic review.
Autorzy:: Burke RM; Clinical Research Department, London School of Hygiene and Tropical Medicine, London, UK.; Malawi Liverpool Wellcome Clinical Research Programme, Queen Elizabeth Central Hospital, Blantyre, Malawi.
Rickman HM; Clinical Research Department, London School of Hygiene and Tropical Medicine, London, UK.; Malawi Liverpool Wellcome Clinical Research Programme, Queen Elizabeth Central Hospital, Blantyre, Malawi.
Pinto C; Global HIV, Hepatitis and STIs Programme, World Health Organisation, Geneva, Switzerland.
Ehrenkranz P; Global Health, Bill & Melinda Gates Foundation, Seattle, Washington, USA.
Choko A; Malawi Liverpool Wellcome Clinical Research Programme, Queen Elizabeth Central Hospital, Blantyre, Malawi.; International Public Health Department, Liverpool School of Tropical Medicine, Liverpool, UK.
Ford N; Global HIV, Hepatitis and STIs Programme, World Health Organisation, Geneva, Switzerland.; Centre for Infectious Disease Epidemiology and Research, School of Public Health and Family Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.; Pokaż więcej
Źródło:: Journal of the International AIDS Society [J Int AIDS Soc] 2024 Mar; Vol. 27 (3), pp. e26230.
Typ publikacji:: Journal Article; Systematic Review
MeSH Terms:: Anti-Retroviral Agents*/therapeutic use
HIV Infections*/epidemiology
Medication Adherence*
Patient Dropouts*
Adolescent ; Female ; Humans ; Male ; Pregnancy ; Developing Countries ; Sexual and Gender Minorities

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""HIV infections"" wg kryterium: Temat

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Język

Rok publikacji